Eligibility Matcher

Select your organization type below to see only the grants you qualify for — sorted by soonest deadline.

542 grants for State governments

Sorted by deadline (soonest first)

USDOT-GCR · GR-RDC-25-001

DOI-FWS · F25AS00332

DOI-FWS · F25AS00379

HHS-NIH11 · PAR-24-280

HHS-NIH11 · PAR-24-279

HHS-NIH11 · PAR-25-255

HHS-NIH11 · PAR-25-095

HHS-NIH11 · RFA-NS-26-001

HHS-NIH11 · RFA-CA-27-002

HHS-NIH11 · RFA-CA-27-001

HHS-NIH11 · PAR-25-271

HHS-NIH11 · PAR-25-269

HHS-NIH11 · PAR-24-089

HHS-NIH11 · PAR-25-270

HHS-NIH11 · PAR-25-370

HHS-NIH11 · PAR-25-274

HHS-NIH11 · PAR-25-268

HHS-NIH11 · PAR-25-267

HHS-NIH11 · PAR-25-158

HHS-NIH11 · PAR-25-096

HHS-NIH11 · PAR-25-371

HHS-NIH11 · PAR-25-369

HHS-NIH11 · PAR-25-052

HHS-NIH11 · PAR-25-226

HHS-NIH11 · PA-23-317

Eligibility Matcher

542 grants for State governments

RESTORE Act Direct Component &ndash; Construction and Real Property Acquisition Activities

F25AS00332 Highlands Conservation Act &ndash; Competitive Funding Round

F25AS00379 Highlands Conservation Act - Base Funding Round

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)

Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)

NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)

Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)

NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)

RESTORE Act Direct Component – Construction and Real Property Acquisition Activities

F25AS00332 Highlands Conservation Act – Competitive Funding Round